News Headlines

1. Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program 6/4/2026

   MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies, and products in the global digital health and medical technology market, today announced that Suvoda, a global leader in clinical trial technology, has been selected as winner of the “Best Patient Relationship Management Solution” award in the 10th annual MedTech Breakthrough Awards program.

2. Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development 5/29/2026
3. Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data 5/12/2026

   The initiative will be implemented in two trials, using Paradigm Health’s integrated technology platform to accelerate FDA review.

4. Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery 5/12/2026

   Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance‑enhancing company, today announced that it has signed an exclusivity agreement with a U.S. biopharmaceutical company (Nasdaq listed, Mcap USD 1Bn+) for the application of Nanoform’s proprietary biologics nanoparticle technology to support the development of differentiated subcutaneous biologic medicines.

5. Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80% 4/24/2026

   The next evolution of Suvoda IRT is designed to accelerate study builds and change orders, elevate user experience, and deliver intelligent insights

6. Signant Health Enters Definitive Agreement To Acquire Ametris 4/17/2026

   Signant Health, the evidence generation company, today announced that it has entered into a definitive agreement to acquire Ametris (formerly ActiGraph), a global digital health solutions provider, subject to customary regulatory processes and approvals and closing conditions.

7. Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities 4/8/2026
8. AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion 4/7/2026

   Biorce expands its U.S. footprint and AI R&D operations by opening a new office in Austin, Texas this week. In Europe, Biorce is already rapidly transforming how Phase I–III clinical trials—up to market approval—are developed.

9. Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities 4/6/2026

   Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Dr. Graham C. Ellis as Clinical Vice President. With more than 25 years of experience as a specialist physician and clinical researcher in diabetes, endocrinology, and metabolic disease, Dr. Ellis brings extensive scientific depth and a distinguished track record as a Principal Investigator across more than 150 international Phase 2–4 clinical trials. His appointment strengthens Signant’s capabilities in supporting sponsors developing treatments in metabolic disease, obesity, and related therapeutic areas.

10. Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets 4/6/2026

    Suvoda, a clinical trial technology company, today announced new split budget functionality within its Budgeting & Benchmarking solution, expanding how sponsors and CROs can manage complex site budget development across global studies and helping to accelerate the up-front work of clinical trials.